January 31, 2023

Conagen

Conagen develops high-purity non-GMO sulforaphane by bioconversion

Commercial production will start in 2023 Expanding on its portfolio of innovative nutritional products through biotechnology, Conagen, announced the development of its 99% high-purity sulforaphane. Made by a proprietary bioconversion technology, the company plans to begin the commercialization path in 2023. Conagen’s bioconversion methods enable the production of sustainable products from many naturally occurring compounds

Conagen commercializes scalable sweetness enhancers from nature

Conagen, the Massachusetts-based biotech firm, announced the commercialization of an expansive portfolio of natural sweetness enhancers for taste modification in sugar reduction solutions for food and beverages. The enhancers are made with precision fermentation, a technology that has led to the innovation of an extensive platform of phenolic antioxidants. Sweetness enhancers in the market today are